Melanie James+FollowFDA Updates COVID Vax Heart WarningThe FDA just told Pfizer and Moderna to beef up their warnings about a rare heart risk (myocarditis) linked to their COVID shots—especially for young men. The new label says it’s 8 cases per million people, mostly guys 12-24. Some experts think the FDA’s move is overkill, since most cases are mild and the risk from COVID itself is worse. Meanwhile, the new CDC panel is shaking things up on vaccine rules. Wild times in vaccine land! #COVID19 #VaccineUpdate #FDA #Health #BodyHealth12931Share
Spencer Brewer+FollowFDA’s Dirty Secret About Your MedsDid you know the FDA has quietly let drug factories with major safety violations keep sending meds to the US—even after banning them? We’re talking about pills and injectables with mold, metal shavings, and even blackish residue. Why? To avoid shortages. The kicker: most of us had no clue, and even some FDA insiders were in the dark. It’s like a game of Russian roulette with our medicine cabinets. Would you trust your meds after hearing this? #FDA #DrugSafety #HealthNews #Health #BodyHealth154Share
Nicholas Coleman+FollowFDA’s Fast Pass: New Drugs on the Express Lane?Heads up: The FDA just announced a new 'fast pass' for drug companies working on what they call 'national priorities.' Translation? If a medicine is seen as important for Americans, it could hit pharmacy shelves in just 1-2 months instead of the usual 10. This could mean quicker access to breakthrough treatments, but it also raises eyebrows—will speed come at the cost of safety? Keep an eye out for new meds popping up faster than your morning coffee brews! #FDA #HealthNews #DrugApproval #Business #Industry1813Share
Stephanie Snow+FollowFDA Let Risky Drugs Slip Through?Did you know the FDA let over 150 drugs or ingredients into the U.S. from factories that were actually banned for safety violations? ProPublica spent a year digging into how generic meds with sketchy histories still end up in our medicine cabinets. Turns out, the FDA didn’t always warn the public or test the drugs once they hit the shelves. Wild, right? Makes you wonder what’s really in those pills! #FDA #DrugSafety #GenericDrugs #Health #BodyHealth50Share
Kevin Rodriguez+FollowModerna’s RSV Shot Just Got a Big BoostModerna’s RSV vaccine just scored FDA approval for younger adults (18-59) with health issues—previously, it was only for those 60+. The move comes as RSV risks for under-60s are often overlooked, but a ton of people in that group have conditions that put them at risk. Meanwhile, vaccine policy is getting a shake-up with RFK Jr. bringing in new advisors (some anti-vax!), and Moderna’s stock is feeling the heat. Big pharma drama and health news all in one! #Moderna #RSV #FDA #Health #BodyHealth90Share
nheath+FollowModerna’s New Covid Shot: What’s the Deal?Moderna just scored FDA approval for a new Covid vaccine, but there’s a catch—it’s only for folks 65+ or those 12-64 with health risks. The new shot, mNexspike, uses just a fifth of the dose of their old vaccine but still packs a punch. It’s not replacing the OG shot, just giving high-risk people another option. Basically, it’s a big move for next-gen vaccines, but don’t expect to see it everywhere just yet! #CovidVaccine #Moderna #FDA #Health1618Share
Melanie James+FollowCucumber Recall Drama: 15 States Hit!Did you hear about the cucumber chaos? The FDA just recalled cucumbers across 15 states after a salmonella outbreak—26 people got sick, and 9 ended up in the hospital! The veggies came from Bedner Growers in Florida and were sold everywhere, even on cruise ships. The worst part? They might not even have labels, so it’s hard to know if you’ve got the bad batch. If you bought cucumbers recently, double-check before you eat! #FoodRecall #Salmonella #FDA #Health41Share
nheath+FollowFDA’s New COVID Vax Plan Has Docs SplitBig shakeup in the COVID vaccine world! The FDA’s advisors just voted to update shots for the JN.1 strain, but the real drama? The FDA’s hinting at a new plan: only high-risk folks and seniors might get recommended for future boosters, not everyone. Experts are totally split on which strain to target next, and there’s a lot of side-eye about how this will affect vaccine makers like Novavax and Sanofi. Meanwhile, political pushback is heating up. Stay tuned—this could change how we all get vaxxed! #COVID19 #FDA #Vaccines #Health01Share
Barry Miller+FollowFDA’s COVID Vax Shake-Up: Only for High-Risk?Big news: The FDA just changed the COVID vaccine game! Now, only folks 65+ or those at high risk are getting the official vax recommendation. No more annual shots for everyone—healthy kids and adults under 65 are off the list unless new trials prove it’s worth it. The move follows super low booster rates and puts the US in line with other countries. Some are worried this could fuel more vaccine hesitancy. What do you think about this switch? #COVID19 #FDA #VaccineUpdate #HealthNews #PublicHealth #Health30Share
Spencer Brewer+FollowCOVID Vax Rules Are Getting a Shake-UpBig changes are coming for COVID-19 vaccines! The FDA wants annual boosters for healthy people under 65 to go through clinical trials first, which means most folks might not get a shot this fall unless they’re older or at higher risk. Plus, Pfizer and Moderna are being told to add warning labels about rare heart inflammation in young men. The science is still evolving, so stay tuned if you’re wondering about your next dose! #COVID19 #VaccineUpdate #FDA #HealthNews #Health141Share